Board of Directors

CED is Now Accepting Nominations for the 2017-2019 Board of Directors

Members of the CED Board of Directors serve two-year terms, starting July 1, 2017, and ending June 30, 2019. Board members are eligible to serve up to three consecutive terms before a break in service. Board members in the the second year of their current term are required to submit an application to be considered to serve another two-year term.

Interested candidates are encouraged to self-nominate by reviewing the Job Description and Requirements here and completing the application:

CED Board of Directors Nomination Form*

Members of CED in good standing may also nominate other individuals, who then will be responsible for completing the application prior to the May 1 deadline. If interested in applying for a one-year term on the Executive Committee, please complete and return the Executive Committee nomination form in addition to the CED Board nomination form. 

All completed applications received by the May 1 deadline will be reviewed by the Governance Committee, which will then nominate officers and a slate of candidates to be considered on June 6 at CED’s Board of Directors meeting.

Questions or comments? Please contact Vicki Schebell at or 919.226.0475

*If you have trouble with the online form, you may download the Word document version here and email the completed application to Vicki Schebell at

Leading by Example: CED’s All-Star Team of Innovators and Visionaries

Led by some of the area’s most talented and successful entrepreneurs, CED’s Board of Directors is committed to the Triangle’s entrepreneurial future. Board Members are elected to two-year terms and Executive Committee members are selected from the Board to serve one-year terms. * = Executive Committee

DeLisa Alexander, Red Hat*

June Almenoff

Tony Atti, Phononic*

James Avery, Adzerk

Elaine Bolle, RTP Capital Associates

Doug Bowers

Bill Brown, 8 Rivers Capital

Rich Brown, PNC Bank

Kimberly Campbell, Mosaic Health Solutions

Glen Caplan, Robinson, Bradshaw & Hinson

Brian Carney, Harbert Venture Partners

Heather Dean, HPG

Joy Parr Drach, Advanced Animal Diagnostics

Scott Duda, Cherry Bekaert

Patrick Dunnigan, River Cities Capital Funds

Ken Eheman, Wyrick Robbins

Stephen Fraser*

Meredith Friga, EY

John Glushik, Intersouth Partners

Matt Godwin, Wells Fargo

Ranya Hahn, VIF International

Dave Haines, Deloitte*

Galen Hatfield, RTI International

Gary Hayes, Scale Finance

Melvin Hines, Upswing

Aaron Houghton, BoostSuite

Nick Jordan, Smashing Boxes

Justyn Kasierski, Hutchison PLLC

Moise Khayrallah, QuatroBio, LLC

Karen LeVert, Southeast TechInventures Inc.

Chris Matton, Bandwidth*

Spence McClelland, Noro-Moseley Partners

Sanjay Pal, Cisco

Kim Phillips, US Trust/BOA

Kevin Prakke, Manning Fulton & Skinner

Anastasia Pucci, GSK

Don Rainey, Grotech Ventures

David Rhode, Vaco Raleigh

Michael Saber, Smith Anderson*

Joe Schachle, Parion Sciences

Brad Schomber, MaxPoint Interactive

Mark Self, Entigral Systems

Christy Shaffer, Hatteras Venture Partners

Jack Sheffield , DB Securities

Oliver Sherrill, Alexandria Real Estate Equities

Giles Shih, BioResource International*

Adam Smith, Automated Insights

Carolyn Sparano, Bronto Software

Bill Spruill, Global Data Consortium

John Stewart, DHG

Chris Stoecker, Silicon Valley Bank

Courtney Tellefson, The Produce Box

Ken Tindall, NC Biotechnology Center

Matt Tormollen, Avalara

Garret Tripp, PwC

Rik Vandevenne, River Cities Capital Funds*

Scott Weiner, Pappas Ventures

Allen West, Railinc

Rich West, Baebies*

Jeff Williams, Clinipace Worldwide*

Deb Woods, SciQuest

Ted Zoller, UNC Kenan-Flagler Bus. School